Data gathered: November 22
AI Stock Analysis - Abbott Laboratories (ABT)
Analysis generated October 15, 2024. Powered by Chat GPT.
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. It was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; it is now a diversified healthcare giant with a market leading position in several domains such as diagnostics, medical devices, nutrition, and branded generic pharmaceuticals. Known for innovation and a strong portfolio of products, Abbott Laboratories has a significant impact on global healthcare markets.
Stock Alerts - Abbott Laboratories (ABT)
 |
Abbott Laboratories | October 24 Insider Alert: ALLEN HUBERT L is selling shares |
|
Abbott Laboratories | September 14 Insider Alert: Ford Robert B is selling shares |
|
Abbott Laboratories | September 13 Josh Gottheimer (member of U.S. congress) is buying shares |
|
Abbott Laboratories | September 5 Insider Alert: MCCOY JOHN A. JR. is selling shares |
Alternative Data for Abbott Laboratories
About Abbott Laboratories
Abbott Laboratories is a health care company that manufactures medical devices, blood glucose monitoring kits, nutritional healthcare products, diagnostic products and equipment, and branded generic drugs.
| Price | $117.26 |
| Target Price | Sign up |
| Volume | 5,540,000 |
| Market Cap | $203B |
| Year Range | $99.6 - $119.39 |
| Dividend Yield | 1.88% |
| PE Ratio | 35.56 |
| Analyst Rating | 85% buy |
| Industry | Health Care Services |
In the news
Abbott Laboratories stock underperforms Wednesday when compared to competitorsNovember 20 - MarketWatch |
|
Abbott Laboratories stock outperforms competitors despite losses on the dayNovember 19 - MarketWatch |
|
 |
Wall Street Bulls Look Optimistic About Abbott (ABT): Should You Buy?November 18 - Yahoo |
Abbott Laboratories stock outperforms competitors on strong trading dayNovember 18 - MarketWatch |
|
Abbott Laboratories : Late Breaking Data Reinforce Long Term Benefits of Abbott's Amplatzer™ Amulet™ Device for People With Atrial Fibrillation at Risk of StrokeNovember 17 - Finnhub |
|
 |
Abbott Laboratories (ABT): A Magnificent Dividend Growth Stock to Buy NowNovember 16 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 10.6B | 8.06B | 2.58B | 1.65B | 2.33B | 1.210 |
| Q2 '24 | 10.4B | 8.01B | 2.37B | 1.3B | 2.14B | 1.140 |
| Q1 '24 | 9.82B | 7.9B | 1.92B | 1.23B | 2.05B | 0.980 |
| Q4 '23 | 10.1B | 8.26B | 1.8B | 1.59B | 2.44B | 1.190 |
| Q3 '23 | 9.99B | 7.82B | 2.16B | 1.44B | 2.33B | 1.140 |
Insider Transactions View All
| ALLEN HUBERT L filed to sell 340,978 shares at $118.8. October 23 '24 |
| ALLEN HUBERT L filed to sell 335,077 shares at $118.2. October 23 '24 |
| ALLEN HUBERT L filed to sell 184,806 shares at $117. October 23 '24 |
| Ford Robert B filed to sell 220,059 shares at $116.9. September 13 '24 |
| Ford Robert B filed to sell 281,439 shares at $116. September 13 '24 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
HCA HealthcareHCA |
$332.24 0% | 58 |
 |
Cardinal HealthCAH |
$123.42 0% | 52 |
 |
Henry ScheinHSIC |
$73.77 0% | 46 |
 |
Idexx LaboratoriesIDXX |
$418.55 0% | 48 |
 |
LabCorpLH |
$240.17 0% | 56 |
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Josh Gottheimer |
Sep 11, 24 | Buy | $1K - $15K |
| John James |
Sep 2, 24 | Buy | $1K - $15K |
| Jared Moskowitz |
Aug 19, 24 | Buy | $1K - $15K |
Read more about Abbott Laboratories (ABT) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
What is the Market Cap of Abbott Laboratories?
The Market Cap of Abbott Laboratories is $203B.
What is Abbott Laboratories' PE Ratio?
As of today, Abbott Laboratories' PE (Price to Earnings) ratio is 35.56.
What is the current stock price of Abbott Laboratories?
Currently, the price of one share of Abbott Laboratories stock is $117.26.
How can I analyze the ABT stock price chart for investment decisions?
The ABT stock price chart above provides a comprehensive visual representation of Abbott Laboratories' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Abbott Laboratories shares. Our platform offers an up-to-date ABT stock price chart, along with technical data analysis and alternative data insights.
Does ABT offer dividends to its shareholders?
Yes, Abbott Laboratories (ABT) offers dividends to its shareholders, with a dividend yield of 1.88%. This dividend yield represents Abbott Laboratories' commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Abbott Laboratories in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
What are some of the similar stocks of Abbott Laboratories?
Some of the similar stocks of Abbott Laboratories are HCA Healthcare, Cardinal Health, Henry Schein, Idexx Laboratories, and LabCorp.
.